The molecular classification of breast cancer is based on the expression of estrogen receptor/progesterone receptor (ER/PR), human epidermal growth factor receptor 2 (HER2) and the proliferative antigen index Ki-67 (145). This evidence concerns the gene ESR1 and breast carcinoma.